North America Mice Model Market (2025-2030)
The North America Mice Model Market was valued at $2.82 Million in 2025 and projected to reach to $3.7 Million by 2030, representing a compound annual growth rate of CAGR 5.6%. North America's mice model market is positioned for steady growth, driven by the region's advanced pharmaceutical development ecosystem and significant investment in preclinical research.
North America Mice Model Market Trends and Insights
- Ksa's healthcare research sector is increasingly adopting genetically modified and disease-specific mouse models to support pharmaceutical development and preclinical testing.
- This steady growth reflects Ksa's commitment to advancing biomedical research infrastructure and regulatory compliance with international standards. Ksa's mice model market benefits from rising investment in life sciences research facilities and collaborations with global pharmaceutical companies.
- The demand for specialized mouse models in Ksa is driven by the region's expanding drug discovery pipelines and growing focus on personalized medicine.
- Between 2025 and 2030, Ksa is expected to see increased adoption of transgenic and knockout mouse models across academic institutions and contract research organizations, supporting the nation's vision for healthcare innovation and scientific excellence..
Key Market Statistics
- CAGR (2025-2030) CAGR 5.6%
- Market Size, 2025 ~USD 2.82 Million
- Forecast, 2030 ~USD 3.7 Million
- Geography North America
North America Mice Model Market Overview
US Market Dominance :
The United States represents the largest mice model market in North America with a market size of USD 889.6 million, driven by robust pharmaceutical R&D infrastructure and leading biotech companies investing heavily in preclinical research.
Canadian Growth Opportunity :
Canada's mice model market is valued at USD 169.8 million, supported by government funding for life sciences research and a growing number of contract research organizations (CROs) specializing in animal model services.
Regional CAGR Performance :
North America's mice model market is projected to grow at a CAGR of 5.6% from 2025 to 2030, reflecting steady demand from pharmaceutical development and academic research institutions across the region.
Genetic Model Adoption :
North American research institutions are increasingly adopting genetically modified and disease-specific mouse models for oncology, neurology, and metabolic disorder studies, supporting market expansion.
North America Mice Model Market Dynamics
- The US and Canada continue to lead in adopting innovative mouse models for drug discovery, with increasing collaboration between academic institutions, biotech firms, and CROs.
- Regulatory support and funding from agencies like the NIH and Canadian Institutes of Health Research further strengthen market fundamentals.
- The market is expected to reach USD 3.70 million by 2030, reflecting sustained demand for specialized animal models in disease research and therapeutic development across the region..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Ksa's mice model market is valued at USD 2.82 million in 2025 with a projected value of USD 3.70 million by 2030.
- Ksa demonstrates a 5.6% CAGR, reflecting steady growth driven by pharmaceutical R&D and preclinical research expansion.
- Ksa's market growth is supported by increased investment in life sciences infrastructure and international research collaborations.
- Ksa is experiencing rising demand for specialized transgenic and disease-specific mouse models in drug discovery and personalized medicine applications.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
North America Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : North American pharma firms require detailed market insights to optimize preclinical research budgets, select CRO partners, and accelerate drug development timelines using advanced mouse models.
- Biotech & CRO Providers : Contract research organizations and biotech firms need regional market data to identify growth opportunities, benchmark services, and expand their mice model offerings across North America.
- Academic Research Institutions : Universities and research centers in the US and Canada use market intelligence to secure funding, justify equipment investments, and collaborate with industry partners on preclinical studies.
- Investment & Private Equity Firms : Investors evaluating opportunities in North American life sciences require market sizing and growth projections to assess the viability of acquisitions and portfolio companies in the mice model sector.
- Regulatory & Government Agencies : NIH, FDA, and Canadian health authorities benefit from market data to understand research trends, allocate funding effectively, and support the development of advanced animal model technologies.
Key Companies in the North America Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 889.6 Million |
| Canada | USD 169.8 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Data : Access precise market valuations for the US (USD 889.6M) and Canada (USD 169.8M) with detailed CAGR projections through 2030, enabling accurate investment and expansion planning.
- Competitive Landscape Intelligence : Understand market dynamics specific to North America's pharmaceutical and biotech sectors, identifying key players and growth opportunities in preclinical research services.
- Regional Trend Analysis : Gain insights into North American adoption patterns of genetically modified and disease-specific mouse models, informing product development and market entry strategies.
- Investment Decision Support : Leverage country-level market data for the US and Canada to evaluate regional expansion opportunities and allocate resources to high-growth segments within North America.
- Regulatory & Funding Context : Understand the North American regulatory environment and government funding landscape (NIH, CIHR) that drives demand for specialized mouse models in research institutions.
Frequently asked questions
What is the current market size of mice models in Ksa?
The Ksa mice model market is valued at USD 2.82 million in 2025.
What is the projected market size for mice models in Ksa by 2030?
Ksa's mice model market is projected to reach USD 3.70 million by 2030.
What is the CAGR for the mice model market in Ksa?
Ksa's mice model market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
What factors are driving growth in Ksa's mice model market?
Growth in Ksa is driven by increased pharmaceutical R&D investment, expansion of life sciences research facilities, and rising demand for specialized transgenic and disease-specific mouse models.
Which sectors in Ksa are the primary consumers of mice models?
Primary consumers in Ksa include pharmaceutical companies, contract research organizations, academic institutions, and biomedical research centers engaged in drug discovery and preclinical testing.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report